Aurora Cannabis reports before the market opens on November 4. Analysts expect a smaller year-over-year loss, but their EPS estimate has fallen over the past month.
Aurora Cannabis Inc. (TSX: ACB) is set to report results for the quarter ended September 30, 2026, before the market opens on November 4. Four analysts expect a loss of C$0.16 per share, while six analysts forecast revenue of C$70.17 million. A month ago, the EPS consensus was a loss of C$0.10 per share, so analysts have lowered their estimate. Aurora beat EPS estimates in two of its last four reported quarters, but results have varied widely. For Canadian investors, the report will show whether the company can build on its international growth while managing ongoing losses.
Recent earnings trend
Aurora Cannabis Inc
ACB.TO
ACB.TO
Aurora Cannabis Inc
WealthAwesomeMarket cap
$358.33M
52W high
$8.75
52W low
$3.59
1W change
+3.66%
Beta
1.42
Analyst Price Targets
Based on analyst covering ACB · as of Oct 26, 2026
Wall Street analysts forecast ACB stock price to rise 2.9% over the next 12 months.
Consensus
NeutralBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.83
+2.9% Upside
Previously C$5.66 on Oct 8, 2026
Current Price
C$5.66
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ACB's historical volatility
30-Day Vol
55.0%
Annualized
90-Day Vol
56.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$6.77
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$6.01 | C$4.97 – C$7.26 |
| 60 trading days | C$6.38 | C$4.88 – C$8.34 |
| 90 trading days | C$6.77 | C$4.87 – C$9.40 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 4 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 2 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-12 | — | -0.0500 | — |
| 2026-06-30 | 2026-08-05 | -0.0700 | -0.2100 | +66.7% |
| 2026-03-31 | 2026-06-11 | -0.9900 | -0.1400 | -607.1% |
| 2025-12-31 | 2026-02-04 | 0.0300 | -0.0800 | +137.5% |
| 2025-09-30 | 2025-11-05 | -0.9100 | -0.1000 | -810.0% |
| 2025-06-30 | 2025-08-06 | -0.2700 | -0.0200 | -1250.0% |
Investor takeaway: The outlook is mixed. Analysts expect a smaller loss than the C$0.91 reported a year ago, but they have lowered their EPS estimate over the past 30 days and forecast a 22.4% drop in revenue. Watch revenue, the source of any sequential growth, and management’s outlook for international operations. Aurora’s recent guidance pointed to contributions from Safari Flower and continued strength in Germany and Poland. Its expanded German EU-GMP facility is also worth watching. As of June 30, 2026, Aurora reported C$149 million in cash and no debt. Still, its latest snapshot shows negative trailing EPS and a negative profit margin. This is an uncertain earnings report, not a straightforward beat-or-miss call.
C$0.16 expected loss per share
Four analysts expect Aurora to lose C$0.16 per share for the quarter ended September 30, compared with a C$0.91 loss a year earlier. But the consensus was a C$0.10 loss 30 days ago. The C$70.17 million revenue estimate also points to a 22.4% year-over-year decline.
Bull case
Aurora beat EPS estimates in two of its last four comparable quarters, including the June 2026 quarter. It reported a C$0.07 loss then, compared with an expected C$0.21 loss. Analysts also expect a much smaller loss this quarter than the C$0.91 loss reported a year ago. If international operations and the expanded German facility support growth, investors may see signs that Aurora’s earnings are improving. The company’s cash and debt position as of June 30 also offers context for its ability to carry out its plans.
Bear case
Aurora’s recent results have been uneven. It missed estimates by a wide margin in the March 2026 and September 2025 quarters, and analysts have lowered their current EPS estimate from a C$0.10 loss to a C$0.16 loss. They also expect revenue to fall 22.4% year over year. The supplied snapshot shows trailing EPS of -C$0.84 and a profit margin of -38.25%. A smaller expected loss alone does not prove the business is turning around. Takeover-related developments add uncertainty, but operating results remain the key measure.
Analysis
Aurora is due to report before the market opens on November 4 for the fiscal quarter ended September 30. Four analysts expect a loss of C$0.16 per share, with estimates ranging from a C$0.24 loss to a C$0.07 loss. Six analysts forecast revenue of C$70.17 million, down 22.4% from a year earlier. The EPS consensus has shifted from a C$0.10 loss a month ago to a C$0.16 loss. One analyst lowered their estimate, and none raised theirs during that period. The expected loss is smaller than the C$0.91 reported a year ago, but the revenue forecast makes operating performance just as important as EPS.
Analysis
Aurora beat EPS estimates in two of its last four reported quarters. That’s a mixed record, not a consistent streak. In June 2026, the company reported a C$0.07 loss, better than the estimated C$0.21 loss, for a positive surprise of 66.67%. In March 2026, it reported a C$0.99 loss against an estimated C$0.14 loss. In December 2025, EPS was C$0.03, compared with an expected loss of C$0.08. In September 2025, Aurora reported a C$0.91 loss against an estimated C$0.10 loss. The recent-earnings table and chart show the quarter-by-quarter results. The main point is that outcomes have varied considerably. See the Aurora Cannabis stock page for company coverage and related data.
Analysis
In its September business update, Aurora reaffirmed its guidance for sequential growth in fiscal Q2 2027. The company pointed to expected contributions from Safari Flower and continued performance in Germany and Poland. It also reported C$149 million in cash and no debt as of June 30, 2026. In October, Aurora said its expanded German EU-GMP facility had received an expanded licence and that it expects annual flower output there to more than double. These are company-reported developments. The earnings release will show whether they are feeding into results. Takeover-related news has also featured in recent headlines, but it should be considered separately from operating performance. Aurora’s trailing EPS is -C$0.84, and its profit margin is -38.25% in the supplied snapshot, showing that the company remains loss-making.
Analysis
Available analyst-target data shows an average target of C$5.83, compared with a last close of C$5.66, implying a 2.9% increase. The consensus label is Neutral, based on the average target relative to the last close. A formal rating is unavailable for this Canadian listing. See the analyst ratings section for target details. Wealth Awesome’s statistical 90-day price model is not financial advice. It gives a mean forecast of C$6.77, with a 68% range of C$4.87 to C$9.40 and a 95% range of C$3.51 to C$13.05. These wide ranges reflect uncertainty. The model is not a price target and does not predict how the stock will react to earnings. See the price prediction section for more details.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
